retatrutide clinical trial results 2024 ESC 2024: improves lipid and cardiovascular risk profile in Phase II Lilly's triple agonist achieves 16.8%
Pay in 4 interest-free payments of $6.57 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
























